Vadivarhe Speciality Chemicals Ltd (VSCL) is currently trading at 24.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Vadivarhe Speciality Chemicals Limited is an Indian specialty chemicals and API manufacturer operating an ISO 9001:2015 and WHO‑GMP certified manufacturing facility at Vadivarhe, Nashik, focused on custom synthesis, intermediates, APIs and personal care intermediates supplying domestic and global formulation manufacturers and registered on the NSE EMERGE SME platform. Financials for H1 FY2026 show revenue from operations of INR 1,704.37 lakhs and total revenue of INR 1,725.48 lakhs, while the company reported a consolidated loss before tax of INR 385.25 lakhs driven by operating expenses exceeding revenue and an elevated cost structure in the period. Operating cash flows improved materially to a net positive INR 544.00 lakhs for the half year, driven largely by a sharp reduction in trade receivables and increases in payables, which converted into cash despite underlying operating losses and persistent financing outflows. Balance sheet indicators reflect elevated leverage with long‑term borrowings of INR 2,009.70 lakhs, short‑term borrowings of INR 1,126.99 lakhs, negative reserves of INR (1,941.13) lakhs and limited cash balances of INR 57.75 lakhs, highlighting capital structure strain and the need for sustained cash generation. Operationally the company has commercially launched more than ten APIs in FY2025 and counts major formulation manufacturers among customers (including GlaxoSmithKline, Lupin and others), indicating successful market access for its WHO‑GMP API output and potential for revenue mix improvement if scale and realizations sustain.

Over the past 52 weeks, Vadivarhe Speciality Chemicals Ltd has traded between a low of ₹16.05 and a high of ₹31.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Vadivarhe Speciality Chemicals Ltd has a market capitalization of approximately 37.13. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Vadivarhe Speciality Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -4.94 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 37.13 Cr, Vadivarhe Speciality Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Vadivarhe Speciality Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Vadivarhe Speciality Chemicals Ltd is -4.94. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.